Hematologic Malignancy

Plasma Cell Neoplasm

HematologicNon-malignant831 active trials25 approved drugs26 evidence items

NCIt: C4665
MeSH: D054219

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (144)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 144 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

[Who refer patients with multiple myeloma to hematology-oncology: A retrospective study at Hôtel-Dieu de France].
Georgy Kattan, Fadi El Karak, Jad Wakim et al. · Bull Cancer · Oct 1, 2026 · PMID 42532709 · candidate dictionary pubmed
De-escalation trials in multiple myeloma: past, present and future.
Hira Mian, Luciano J Costa, Mohamad Mohty et al. · Nat Rev Clin Oncol · Oct 1, 2026 · PMID 42527555 · candidate dictionary pubmed
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.
Estefania Gauto Mariotti, Shaji Kumar, Wilson Gonsalves et al. · Leukemia · Oct 1, 2026 · PMID 42481797 · candidate dictionary pubmed
Multiple myeloma diagnosed after contrast-enhanced computed tomography without renal complications: a case report with literature review.
Keiko Kudoh, Takaharu Kudoh, Yasuhiko Morita et al. · Oral Radiol · Oct 1, 2026 · PMID 42479293 · candidate dictionary pubmed
Clinical and Metabolic Outcomes of Radiofrequency Ablation with Vertebral Augmentation for Symptomatic Spinal Osteolytic Lesions in Multiple Myeloma.
Pooya Torkian, Jens Hillengass, Younes Jahangiri et al. · J Vasc Interv Radiol · Oct 1, 2026 · PMID 42468838 · candidate dictionary pubmed
Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.
Vasiliki Kostiou, Vijayalakshmi Chelliah, Piet H van der Graaf et al. · Clin Pharmacol Ther · Oct 1, 2026 · PMID 42364971 · candidate dictionary

pubmed

Efficiency of Automated and Manual Plasma Cell Immunoselection for FISH Analysis in Multiple Myeloma.

Helena Podgornik, Katarina Reberšek · Int J Lab Hematol · Oct 1, 2026 · PMID 42332409 · candidate dictionary pubmed

Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments.

Amir M Ansari, Sogol Attaripour, Sahil Garg et al. · Cancer Invest · Oct 1, 2026 · PMID 42323950 · candidate dictionary pubmed

Energy-resolved attenuation behaviour on dual-source photon-counting CT: Implications for quantitative assessment of femoral bone marrow in multiple myeloma.

Anke Heidemeier, Franzisca Scheiner, Henner Huflage et al. · Eur J Radiol · Oct 1, 2026 · PMID 42289153 · candidate dictionary pubmed

Promoter Methylation of HOXA5 and NDRG2 in Multiple Myeloma Patients with Renal Impairment.

Riham Abdel-Hamid Haroun, Dina Samir Elsaid, Mona A Al-Dosoky et al. · Biochem Genet · Oct 1, 2026 · PMID 42258087 · candidate dictionary pubmed

Junctional Adhesion Molecule-A (JAM-A) Associates With High-Risk Disease in Multiple Myeloma Patients and a Structure-Based Rationally-Designed Peptide Inhibitor Attenuates Tumorigenic Features In Vitro and In Vivo.

Niamh McAuley, Roisin McAvera, Dimitri Bong et al. · Eur J Haematol · Oct 1, 2026 · PMID 42204384 · candidate dictionary pubmed

Photon-counting detector computed tomography (PCD-CT) in multiple myeloma: a systematic review and trial sequential meta-analysis on image quality and radiation dose.

Victor Arthur Ohannesian, Bruna Colabono Taneja, Adham do Amaral E Castro et al. · Skeletal Radiol · Oct 1, 2026 · PMID 42204008 · candidate dictionary pubmed

Circadian Deregulation in Multiple Myeloma: BMAL1/CLOCK Expression Patterns and Diagnostic Performance.

Hamide Albayrak, Mustafa Ertan Ay, Anıl Tombak et al. · Int J Lab Hematol · Oct 1, 2026 · PMID 42167790 · candidate dictionary pubmed

Condensed vs. Standard Step-Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma.

Grace Elsey, James A Davis, Kelley Julian et al. · Eur J Haematol · Oct 1, 2026 · PMID 42150762 · candidate dictionary pubmed

Sustained IL-15 release enhances CAR-T therapy in multiple myeloma via FOXO1 signaling axis activation.

Kuai Yu, Yunxin Zeng, Bo Lu et al. · Biomaterials · Oct 1, 2026 · PMID 41936184 · candidate dictionary pubmed

Safety, effectiveness and pharmacokinetics of high-dose propylene glycol-free melphalan (EVOMELA) with a prolonged infusion as myeloablative conditioning in Chinese multiple myeloma patients undergoing autologous stem cell transplantation: A prospective phase iv study.

Fengrong Wang, Zhen Cai, Dehui Zou et al. · J Oncol Pharm Pract · Oct 1, 2026 · PMID 40296724 · candidate dictionary pubmed

Abemaciclib and lenalidomide presenting with central retinal artery occlusion in a patient with breast cancer and multiple myeloma: a possible treatment-related association.

Manas Pustake, Stevenson Ongsyping, Jesus Gomez et al. · BMJ Case Rep · Sep 28, 2026 · PMID 42805625 · candidate dictionary pubmed

NSD2 degradation remediates the oncogenic cistrome in t(4;14) multiple myeloma.

Bo Hu, Jacob T Edwards, Hardik Modi et al. · Blood · Sep 24, 2026 · PMID 42371798 · candidate dictionary pubmed

Evolution of real-world frontline treatment patterns in multiple myeloma.

Alexander Lazzaro, Kaelyn Nannini, Cenk Yildirim et al. · Blood Adv · Sep 22, 2026 · PMID 42480210 · candidate dictionary pubmed

AI-derived whole-body MRI metrics in patients with multiple myeloma reveal unique insights into body composition and outcomes.

Nicolas Basty, Martin Kaiser, Charlotte Pawlyn et al. · Blood Adv · Sep 22, 2026 · PMID 42418394 · candidate dictionary pubmed

Exploring the psychological impact and healthcare experiences of patients living with triple class refractory multiple myeloma: an interpretative phenomenological analysis study.

Noreen Ali, Luke Kuttschreuter, Sandra Quinn et al. · BMJ Open · Sep 21, 2026 · PMID 42767746 · candidate dictionary pubmed

Psychometric evaluation of the PROMIS® Medication Adherence Scale among patients prescribed oral anticancer medication for multiple myeloma.

Sarah M Belcher, Paul Scott, Susan M Sereika et al. · J Patient Rep Outcomes · Sep 19, 2026 · PMID 42791413 · candidate dictionary pubmed

SEI1 complex silences p53 to drive myeloma progression.

Rui Chen, Rui Liu, Zhihong Fang et al. · iScience · Sep 18, 2026 · PMID 42698665 · candidate dictionary pubmed

Two decades of progress, persistent inequity: national trends in multiple myeloma mortality in the United States, 1999-2024.

Mohammad Eisa Ali, Federico Ferrari, Ali Shan Hafeez et al. · Cancer Causes Control · Sep 18, 2026 · PMID 42754761 · candidate dictionary pubmed

PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma.

Anaïs Schavgoulidze, Jian Cui, Jessica Encinas Mayoral et al. · Blood · Sep 17, 2026 · PMID 42237635 · candidate dictionary pubmed